3 research outputs found

    Kirche im Dienst der Publizistik

    Get PDF
    Die hier folgenden Gedanken spiegeln die Erfahrung eines kanadischen Bischofswider. Er lebt inmitten einer pluralistischen Gesellschaft in einem zweisprachigenLand, in dem die Massenkommunikationsmittel größtenteils kommerziellen Rücksichten unterliegen. Meine Überlegungen stimmen in der Linie mit dem Zweiten Vatikanum überein. Das Konzil rief uns ja u. a. folgende Wahrheiten ins Gedächtnis: Wir sind ein Pilgervolk und haben keine bleibende Heimat hier. (...)EnglishThe Canadian Bishop de Roo in his speech at the UNDA General Assembly in New Orleans asks if the church as well as putting the means of social communication at her "service" should not "serve" the world of social communications. This "service" would mean e. g. to recognize the real nature of the social communications media in order to respect their true potential; to accept dialogue; to recognize the signs of the times and discern in them the presence of god; to listen to what the world is saying to us through the media; to accept the various expressions of truth without wishing to channel them only along the familiar lines of a changing culture

    Collegiality and the Petrine Office in the pastoral mission of the Church

    No full text

    Antimüllerian hormone levels decrease in female-to-male transsexuals using testosterone as cross-sex therapy

    No full text
    Objective: To investigate the effect of hormonal androgenic treatment on antimullerian hormone (AMH) serum levels in female-to-male (FtM) transsexuals. Polycystic ovary syndrome (PCOS) is associated with elevated AMH levels. Some hypothesize that the high AMH level is a consequence of androgen-induced excessive development of small antral follicles. However, this role of androgens is not yet clear. Design: Observational, prospective, cohort study. Setting: Tertiary academic medical center. Patient(s): Twenty-two FtM transsexuals, healthy native females receiving cross-sex hormone therapy/androgenic treatment. Intervention(s): Androgenic treatment with testosterone (T) and an aromatase inhibitor while endogenous hormone secretion was suppressed with the use of a GnRH agonist. Main Outcome Measure(s): Hormone concentrations were measured before and after androgenic treatment (administration of T and aromatase inhibitor). Measured hormones: AMH, inhibin B, T, androstenedione, DHEAS, E-2, SHBG, LH, and FSH. Result(s): AMH concentrations were significantly lower after androgenic treatment (4.4 +/- 4.4 mg/L vs. 1.4 +/- 2.1 mg/L). Androgenic treatment resulted in a strong suppression of AMH secretion over a relative short period of 16 weeks. Conclusion(s): Our data underscore the likely important role of androgens in the dynamics of folliculogenesis. It challenges the idea that androgens induce high AMH levels, which is gaining more interest nowadays as an important particular PCOS feature. This strong decline furthermore indicates that AMH must be interpreted in the context of other reproductive endocrine conditions. Clinical Trial Registration Number: NTR2493. (C) 2015 by American Society for Reproductive Medicine
    corecore